[go: up one dir, main page]

ZA928878B - New oligodeoxybonucleotides having anti-ischemic activity and methods of preparation thereof. - Google Patents

New oligodeoxybonucleotides having anti-ischemic activity and methods of preparation thereof.

Info

Publication number
ZA928878B
ZA928878B ZA9228878A ZA9228878A ZA928878B ZA 928878 B ZA928878 B ZA 928878B ZA 9228878 A ZA9228878 A ZA 9228878A ZA 9228878 A ZA9228878 A ZA 9228878A ZA 928878 B ZA928878 B ZA 928878B
Authority
ZA
South Africa
Prior art keywords
oligodeoxybonucleotides
preparation
new
methods
ischemic activity
Prior art date
Application number
ZA9228878A
Other languages
English (en)
Inventor
Ennio Lanzarotti
Marisa Mantovani
Guiseppe Prino
Roberto Porta
Armando Cedro
Danilo Moltrasio
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of ZA928878B publication Critical patent/ZA928878B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA9228878A 1991-12-09 1992-11-17 New oligodeoxybonucleotides having anti-ischemic activity and methods of preparation thereof. ZA928878B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913294A IT1252174B (it) 1991-12-09 1991-12-09 Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento

Publications (1)

Publication Number Publication Date
ZA928878B true ZA928878B (en) 1993-06-22

Family

ID=11361289

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9228878A ZA928878B (en) 1991-12-09 1992-11-17 New oligodeoxybonucleotides having anti-ischemic activity and methods of preparation thereof.

Country Status (17)

Country Link
US (3) US6046172A (xx)
EP (1) EP0558833A3 (xx)
JP (1) JPH05247083A (xx)
CN (1) CN1073448A (xx)
AU (1) AU655087B2 (xx)
BE (1) BE1008163A5 (xx)
BR (1) BR9204931A (xx)
CA (1) CA2083416A1 (xx)
CH (1) CH685298A5 (xx)
FR (1) FR2684675B1 (xx)
GR (1) GR1002143B (xx)
IL (1) IL103757A (xx)
IT (1) IT1252174B (xx)
LU (1) LU88197A1 (xx)
MX (1) MX9207137A (xx)
PT (1) PT101113A (xx)
ZA (1) ZA928878B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
EP1202750A4 (en) * 1997-04-28 2002-10-16 Arsinur Burcoglu METHOD FOR THE TREATMENT OF HIV INFECTIONS AND THEIR OPPORTUNISTIC INFECTIONS
DK1059092T3 (da) * 1999-06-08 2006-03-27 Gentium Spa Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter
EP1325962A1 (en) * 2001-12-17 2003-07-09 Gentium S.p.A. A method for determining the biological activity of defibrotide
MXPA05003469A (es) * 2002-10-01 2005-06-03 Truck Lite Co Faro delantero con diodo emisor de luz y montaje de faro delantero.
US7270723B2 (en) * 2003-11-07 2007-09-18 Kimberly-Clark Worldwide, Inc. Microporous breathable elastic film laminates, methods of making same, and limited use or disposable product applications
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
CA2598613A1 (en) * 2005-03-03 2006-09-14 Gentium S.P.A. Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors
ITMI20050336A1 (it) * 2005-03-03 2006-09-04 Gentium Spa Formulazione ad attivita' anti-tumorale
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
CA2874960C (en) 2012-06-22 2021-05-18 Gentium S.P.A. Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
TW201909904A (zh) 2017-08-03 2019-03-16 愛爾蘭商爵士製藥愛爾蘭有限責任公司 高濃度調配物
CA3095335A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
EP4135717A1 (en) 2020-04-17 2023-02-22 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB808296A (en) * 1955-10-05 1959-02-04 Roland Vercambre Process for the extraction of nucleic acid and for the preparation of the salts thereof
DE1142365B (de) * 1955-10-05 1963-01-17 Roland Vercambre Verfahren zur Gewinnung von Nucleinsaeure und deren Salze aus Fischmilch
FR1245818A (fr) * 1959-11-27 1960-10-03 Procédé de préparation d'acides désoxyribonucléiques à haut degré de polymérisation
FR1408585A (fr) * 1964-09-22 1965-08-13 Schwarz Biores Isolement et purification de bases hétérocycliques
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
JPS5217040B2 (xx) * 1972-12-07 1977-05-12
SU780444A1 (ru) * 1979-06-25 1985-04-23 Специальное Конструкторско-Технологическое Бюро Биологически Активных Веществ Главного Управления Микробиологической Промышленности При Совете Министров Ссср Способ получени дезоксирибонуклеиновой кислоты
US4417046A (en) * 1981-08-24 1983-11-22 Eli Lilly And Company Process for isolating oligonucleotide product from a coupling reaction mixture
DE3308932A1 (de) * 1983-03-12 1984-09-13 Hoechst Ag, 6230 Frankfurt Verfahren zur abtrennung von ribonukleinsaeuren aus einer loesung, die desoxyribonukleinsaeuren enthaelt
SU1161511A1 (ru) * 1983-07-01 1985-06-15 Институт биоорганической химии АН БССР Способ осаждени нуклеиновых кислот из растворов,содержащих фосфатный буфер
JPS6036493A (ja) * 1983-08-08 1985-02-25 Nippon Zeon Co Ltd 保護された核酸関連物質の分離法
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
DE3782427T2 (de) * 1986-10-06 1996-07-18 Univ Virginia Verwendung einer adenosin, hypoxanthin und ribose enthaltender lösung zur schonung des herzens während chirurgischer eingriffe.
US4833239A (en) * 1987-01-29 1989-05-23 Genetics Institute, Inc. Method for the isolation and purification of DNA molecules
US5063162A (en) * 1987-04-24 1991-11-05 Hoffmann-La Roche Inc. Process for isolating nucleic acids utilizing protease digestion
AU635207B2 (en) * 1989-05-22 1993-03-18 Genetics Institute Inc. Improved composition for isolating and purifying nucleic acid and improved method using same
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids

Also Published As

Publication number Publication date
GR1002143B (en) 1996-02-16
PT101113A (pt) 1994-02-28
US5646127A (en) 1997-07-08
LU88197A1 (fr) 1993-05-17
FR2684675A1 (fr) 1993-06-11
IL103757A (en) 1997-02-18
CA2083416A1 (en) 1993-06-10
AU655087B2 (en) 1994-12-01
ITMI913294A1 (it) 1993-06-09
JPH05247083A (ja) 1993-09-24
BR9204931A (pt) 1993-06-15
EP0558833A2 (en) 1993-09-08
US5646268A (en) 1997-07-08
BE1008163A5 (fr) 1996-02-06
EP0558833A3 (en) 1995-09-06
CH685298A5 (fr) 1995-05-31
ITMI913294A0 (it) 1991-12-09
IT1252174B (it) 1995-06-05
GR920100527A (el) 1994-03-31
US6046172A (en) 2000-04-04
MX9207137A (es) 1993-08-01
FR2684675B1 (fr) 1996-10-18
CN1073448A (zh) 1993-06-23
AU2968592A (en) 1993-06-10

Similar Documents

Publication Publication Date Title
ZA928878B (en) New oligodeoxybonucleotides having anti-ischemic activity and methods of preparation thereof.
EP0572025A3 (en) Furniture construction and manufacturing method.
GR3017062T3 (en) Piperidine compounds and their preparation and use.
ZA923516B (en) New thiopyranopyrrole derivatives and their preparation
GB2255503B (en) Improved use of ß2-bronchodilator drugs
CS20091A2 (en) Basic calciumaluminiumhydroxidedicarboxylate, method of its preparation and its application
PL296034A2 (en) Composition exibiting-fgf activity and method of obtaining same
EP0454726A4 (en) Hindered linking agents and methods
EP0344110A3 (en) Substituted naphthacenes-5,12-diones and their use
EP0421436A3 (en) Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity
PL297839A1 (en) Novel hetaryloxy-beta-carbolines, method of obtaining them and their use in drugs
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
JPS6468346A (en) Substituted anilinophenylthiourea, anilinophenylisothiourea and anilinophenylcarbodiimide
IL88880A0 (en) Cyano-dienes and halopyridines and their preparation
EP0344109A3 (en) Substituted naphthacene-5,12-diones and their use
IL102467A0 (en) Substituted pyridines and their preparation
IL87779A0 (en) 4-azasaccharines,4-aza-dihydro-and-tetrahydro-saccharines and their preparation
ZA889251B (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
GR3017784T3 (en) Substituted dibenzofurans and methods of using same.
GB9124492D0 (en) Hoof hardeners,waterproofers and methods
ZA882852B (en) Pyrrolealdehydes,their preparation and their use
AU5348694A (en) Octahydronaphthoquinolizines, and methods of making and using thereof
EP0393339A3 (en) Preparation of pre-caseinates, and use
PL297872A1 (en) Substituted sulfonylbenzyloimidazopyridines, method of obtaining them and drugs containing them
JPS6466148A (en) Manufacture of 1,5-diaminoheptanol-6, manufacture and use